Header Logo

Connection

TARIQ SHAFI to Risk Factors

Back to Details
This is a "connection" page, showing publications TARIQ SHAFI has written about Risk Factors.
TARIQ SHAFI
Connection Strength
0.880
Risk Factors
  1. Individualized Risk of CKD Progression among US Adults. J Am Soc Nephrol. 2024 Aug 01; 35(8):1076-1083.
    View in: PubMed
    Score: 0.076
  2. Incidence and Risk Factors for Pruritus in Patients with Nondialysis CKD. Clin J Am Soc Nephrol. 2023 02 01; 18(2):193-203.
    View in: PubMed
    Score: 0.069
  3. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES). BMC Nephrol. 2019 04 25; 20(1):138.
    View in: PubMed
    Score: 0.053
  4. Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Sudden Cardiac Death. Clin J Am Soc Nephrol. 2018 09 07; 13(9):1429-1431.
    View in: PubMed
    Score: 0.051
  5. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated?with?cardiovascular outcomes. Kidney Int. 2017 12; 92(6):1484-1492.
    View in: PubMed
    Score: 0.047
  6. Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. BMC Nephrol. 2016 Feb 20; 17:18.
    View in: PubMed
    Score: 0.043
  7. Serum ?-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2012 Sep; 7(9):1435-45.
    View in: PubMed
    Score: 0.033
  8. Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III). BMC Nephrol. 2012 Jun 15; 13:42.
    View in: PubMed
    Score: 0.033
  9. Polyomavirus-associated nephropathy: a comparison of 2 different strategies for immunosuppression reduction. Medicine (Baltimore). 2011 Sep; 90(5):296-302.
    View in: PubMed
    Score: 0.031
  10. Changes in serum potassium mediate thiazide-induced diabetes. Hypertension. 2008 Dec; 52(6):1022-9.
    View in: PubMed
    Score: 0.026
  11. Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY. J Diabetes Complications. 2026 Apr; 40(4):109274.
    View in: PubMed
    Score: 0.021
  12. Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of CRIC and PACE studies. Nat Commun. 2025 Nov 27; 16(1):11689.
    View in: PubMed
    Score: 0.021
  13. Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function. Kidney Int. 2023 05; 103(5):949-961.
    View in: PubMed
    Score: 0.017
  14. Albuminuria and Heart?Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 01 24; 81(3):270-282.
    View in: PubMed
    Score: 0.017
  15. Deoxycholic Acid and Coronary Artery Calcification in the Chronic Renal Insufficiency Cohort. J Am Heart Assoc. 2022 04 05; 11(7):e022891.
    View in: PubMed
    Score: 0.016
  16. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study. J Am Soc Nephrol. 2022 03; 33(3):601-611.
    View in: PubMed
    Score: 0.016
  17. Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2022 01; 79(1):36-44.e1.
    View in: PubMed
    Score: 0.015
  18. Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2021 03; 32(3):639-653.
    View in: PubMed
    Score: 0.015
  19. Antihyperglycemic Therapies With Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns Within an Academic Medical Center. J Cardiovasc Pharmacol. 2020 09; 76(3):313-320.
    View in: PubMed
    Score: 0.015
  20. Lower levels of proteinuria are associated with elevated mortality in incident dialysis patients. PLoS One. 2019; 14(12):e0226866.
    View in: PubMed
    Score: 0.014
  21. Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. Hemodial Int. 2020 01; 24(1):43-51.
    View in: PubMed
    Score: 0.014
  22. Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020 03; 75(3):394-403.
    View in: PubMed
    Score: 0.014
  23. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression. JAMA Intern Med. 2019 04 01; 179(4):542-551.
    View in: PubMed
    Score: 0.013
  24. Vascular Calcification Markers and Hemodialysis Vascular Access Complications. Am J Nephrol. 2018; 48(5):330-338.
    View in: PubMed
    Score: 0.013
  25. Burden and correlates of readmissions related to pulmonary edema in US hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2018 07 01; 33(7):1215-1223.
    View in: PubMed
    Score: 0.013
  26. Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. BMC Nephrol. 2018 06 26; 19(1):150.
    View in: PubMed
    Score: 0.013
  27. Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study. Sci Rep. 2018 03 16; 8(1):4718.
    View in: PubMed
    Score: 0.012
  28. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study. J Diabetes. 2018 Apr; 10(4):276-285.
    View in: PubMed
    Score: 0.012
  29. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2017 Sep; 70(3):337-346.
    View in: PubMed
    Score: 0.012
  30. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol. 2015; 42(1):25-34.
    View in: PubMed
    Score: 0.010
  31. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Aug 07; 16:131.
    View in: PubMed
    Score: 0.010
  32. Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Apr 24; 16:63.
    View in: PubMed
    Score: 0.010
  33. Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. Nephrol Dial Transplant. 2015 Apr; 30(4):667-75.
    View in: PubMed
    Score: 0.010
  34. Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study. BMC Nephrol. 2014 May 01; 15:68.
    View in: PubMed
    Score: 0.009
  35. Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol. 2014 Apr; 9(4):745-55.
    View in: PubMed
    Score: 0.009
  36. Trends in anemia management in US hemodialysis patients 2004-2010. BMC Nephrol. 2013 Dec 01; 14:264.
    View in: PubMed
    Score: 0.009
  37. Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. BMC Nephrol. 2013 Nov 12; 14:249.
    View in: PubMed
    Score: 0.009
  38. Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study. J Gen Intern Med. 2014 Feb; 29(2):290-7.
    View in: PubMed
    Score: 0.009
  39. Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis. 2013 Jun; 61(6):966-74.
    View in: PubMed
    Score: 0.009
  40. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol. 2012 Dec 06; 13:167.
    View in: PubMed
    Score: 0.009
  41. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012 May; 59(5):653-62.
    View in: PubMed
    Score: 0.008
  42. Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2011 May; 93(5):1087-91.
    View in: PubMed
    Score: 0.008
  43. Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 2010 Oct 25; 170(19):1745-51.
    View in: PubMed
    Score: 0.007
  44. Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S92-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.